Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D H Lau

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Seminars in Oncology|August 1, 1997
Twice-weekly paclitaxel and radiation for stage III non-small cell lung cancerD H Lau, J K Ryu, D R Gandara, et al.
Journal of Neurophysiology|June 30, 2001
KT3.2 and KT3.3, two novel human two-pore K(+) channels closely related to TASK-1E Vega-Saenz de Miera, D H Lau, M Zhadina, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Differential single- versus double-strand DNA breakage produced by doxorubicin and its morpholinyl analoguesG E Duran, D H Lau, A D Lewis, et al.
Journal of Computer Assisted Tomography|December 1, 1982
Biodistribution study of Ethiodized Oil Emulsion 13 for computed tomography of the liver and spleenM Vermess, D H Lau, M D Adams, et al.
Internal Medicine Journal|June 6, 2013
Trends in the use of implantable cardioverter defibrillators in Australia: a 10-year nationwide study from 2000-2009A W T Burch, C X Wong, T Sullivan, et al.
Investigative Radiology|November 1, 1980
synthesis and biological testing of nonionic iodinated x-ray contrast mediaG B Hoey, R M Hopkins, K R Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Southwest Oncology Group phase II trial of concurrent carboplatin, etoposide, and radiation for poor-risk stage III non-small-cell lung cancerD H Lau, J J Crowley, D R Gandara, et al.
Cancer Chemotherapy and Pharmacology|November 7, 1999
Treatment of poor-prognosis extensive disease small-cell lung cancer with an all-oral regimen of etoposide and cyclophosphamide - a Southwest Oncology Group clinical and pharmacokinetic studyS M Grunberg, J Crowley, K R Hande, et al.
Internal Medicine Journal|October 24, 2009
Evidence-based management of heart failure in clinical practice: a review of device-based therapy useS Thavapalachandran, D P Leong, M K Stiles, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollmentP N Lara, R Higdon, N Lim, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Seminars in Oncology|August 1, 1997
Twice-weekly paclitaxel and radiation for stage III non-small cell lung cancerD H Lau, J K Ryu, D R Gandara, et al.
Journal of Neurophysiology|June 30, 2001
KT3.2 and KT3.3, two novel human two-pore K(+) channels closely related to TASK-1E Vega-Saenz de Miera, D H Lau, M Zhadina, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Differential single- versus double-strand DNA breakage produced by doxorubicin and its morpholinyl analoguesG E Duran, D H Lau, A D Lewis, et al.
Journal of Computer Assisted Tomography|December 1, 1982
Biodistribution study of Ethiodized Oil Emulsion 13 for computed tomography of the liver and spleenM Vermess, D H Lau, M D Adams, et al.
Internal Medicine Journal|June 6, 2013
Trends in the use of implantable cardioverter defibrillators in Australia: a 10-year nationwide study from 2000-2009A W T Burch, C X Wong, T Sullivan, et al.
Investigative Radiology|November 1, 1980
synthesis and biological testing of nonionic iodinated x-ray contrast mediaG B Hoey, R M Hopkins, K R Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Southwest Oncology Group phase II trial of concurrent carboplatin, etoposide, and radiation for poor-risk stage III non-small-cell lung cancerD H Lau, J J Crowley, D R Gandara, et al.
Cancer Chemotherapy and Pharmacology|November 7, 1999
Treatment of poor-prognosis extensive disease small-cell lung cancer with an all-oral regimen of etoposide and cyclophosphamide - a Southwest Oncology Group clinical and pharmacokinetic studyS M Grunberg, J Crowley, K R Hande, et al.
Internal Medicine Journal|October 24, 2009
Evidence-based management of heart failure in clinical practice: a review of device-based therapy useS Thavapalachandran, D P Leong, M K Stiles, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollmentP N Lara, R Higdon, N Lim, et al.
Pageof 5